10-K Decoder · All companies

Haemonetics Corporation

HAE · FY2026 · Fiscal year ended Mar 28, 2026 · 10-K filed May 2026

Open the dashboardInfographicSummary

FY2026 key figures

$FY2026FY2025Change
Revenue$1.33B$1.36B−2.0%
Operating income$157M$222M−29.3%
Net income$97.3M$168M−42.0%

Latest quarter: Q2 FY2027

Form 10-Q · Three months ended Sep 26, 2026 · filed Nov 5, 2026

$Q2 FY2027Year earlierChange
Revenue$358M$327M+9.3%
Operating income$75.1M$58.5M+28.4%
Net income$46.3M$38.7M+19.6%

Q2 FY2027 dashboardQ2 FY2027 infographic

Questions

What was Haemonetics's revenue in FY2026?
$1.33B in FY2026 (Fiscal year ended Mar 28, 2026), −2.0% vs $1.36B a year earlier, per its 10-K filed May 2026.
Was Haemonetics profitable in FY2026?
Yes: net income was $97.3M and operating income $157M in FY2026.
What was Haemonetics's revenue in Q2 FY2027?
$358M (+9.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.